Clinical Trial Update: Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate [NA]

View source ↗

Summary

This clinical trial update reports an evaluation of gait in multiple sclerosis patients treated with glatiramer acetate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• COPAXONE (GLATIRAMER ACETATE)

Snippet

Sponsor: Sheba Medical Center | Conditions: Multiple Sclerosis | NA | Status: UNKNOWN